Browsen in EconStor gesamt nach Autor:innen Gandjour, Afschin
Zeige Ergebnisse 1 bis 7 von 7
Erscheinungsjahr | Titel | Autor:innen |
2020 | Predictors of negotiated prices for new drugs in Germany | Gandjour, Afschin; Schüßler, Sofia; Hammerschmidt, Thomas; Dintsios, Charalabos-Markos |
2021 | Financial Incentives in the Path to Recovery from the COVID-19 Pandemic | Gandjour, Afschin |
2022 | Demonstrating the value of cancer biomarkers at the population level | Gandjour, Afschin |
2023 | Impact of the introduction of the AMNOG law on launch delays of new drugs in Germany: a comment | Gandjour, Afschin |
2023 | A Model-Based Estimate of the Cost-Effectiveness Threshold in Germany | Gandjour, Afschin |
2023 | Comment on: “10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?” | Gandjour, Afschin |
2023 | Comment on: “10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?” | Gandjour, Afschin |